[Clinical study of a new beta-blocking agent: LB 46].
D000083:Acetanilides / Q000008:administration & dosage; D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage; D000328:Adult; D000368:Aged; D000605:Amino Alcohols / Q000008:administration & dosage*; D000787:Angina Pectoris / Q000188:drug therapy*; D001145:Arrhythmias, Cardiac / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011437:Propylamines / Q000008:administration & dosage; D013565:Sympatholytics / Q000008:administration & dosage*
D000083:Acetanilides; D000319:Adrenergic beta-Antagonists; D000605:Amino Alcohols; D011437:Propylamines; D013565:Sympatholytics
Etude clinique d'un nouvel agent bêta-bloquant: le LB 46.